about
Common Variable Immunodeficiency or Late-Onset Combined Immunodeficiency: A New Hypomorphic JAK3 Patient and Review of the LiteratureEpidemiology and pathophysiology of malignancy in common variable immunodeficiency?Selective IgA Deficiency: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management.Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management.Autoimmunity in primary T-cell immunodeficiencies.A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency.Next Generation Sequencing Data Analysis in Primary Immunodeficiency Disorders - Future Directions.Presence of Idiopathic Thrombocytopenic Purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency.Evaluation of humoral immune function in patients with chronic idiopathic thrombocytopenic purpura.Alteration in frequency and function of CD4⁺CD25⁺FOXP3⁺ regulatory T cells in patients with immune thrombocytopenic purpura.Costs of Hospital Admission on Primary Immunodeficiency Diseases.The probable role of cytomegalovirus in acute myocardial infarction.Evaluation of physicians' awareness of pediatric diseases in iran.RAC2 loss-of-function mutation in 2 siblings with characteristics of common variable immunodeficiency.Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995-2014.Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiencyEvaluation of antibody response to polysaccharide vaccine and switched memory B cells in pediatric patients with inflammatory bowel diseaseCutaneous granulomas in common variable immunodeficiency: case report and review of literature.Indications and safety of intravenous and subcutaneous immunoglobulin therapy.Autoimmunity in X-linked agammaglobulinemia: Kawasaki disease and review of the literature.Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysis.The approach to children with recurrent infections.A review on guidelines for management and treatment of common variable immunodeficiency.Combined immunodeficiency presenting with vaccine-associated paralytic poliomyelitis: a case report and narrative review of literature.Molecular diagnosis of primary immunodeficiency diseases in a developing country: Iran as an example.Genetic defects in B-cell development and their clinical consequences.Important differences in the diagnostic spectrum of primary immunodeficiency in adults versus children.Novel mutations in TNFRSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency.Different brands of intravenous immunoglobulin for primary immunodeficiencies: how to choose the best option for the patient?Clinical phenotype classification for selective immunoglobulin A deficiency.Managing patients with side effects and adverse events to immunoglobulin therapy.A Comparison of Clinical and Immunologic Phenotypes in Familial and Sporadic Forms of Common Variable Immunodeficiency.Spectrum of Phenotypes Associated with Mutations in LRBA.Role of apoptosis in common variable immunodeficiency and selective immunoglobulin A deficiency.Primary Antibody Deficiency in a Tertiary Referral Hospital: A 30-Year Experiment.Evaluation of Known Defective Signaling-Associated Molecules in Patients Who Primarily Diagnosed as Common Variable Immunodeficiency.Clinical, immunologic, molecular analyses and outcomes of iranian patients with LRBA deficiency: A longitudinal study.Monogenic mutations associated with IgA deficiency.Early onset steroid induced posterior subcapsular cataract in a patient with common variable immunodeficiency: case reports and review of literature.Cellular and molecular mechanisms of immune dysregulation and autoimmunity.
P50
Q26800165-9CA5B727-0A42-41F7-B648-EFE1CFFCF743Q30234781-5F56E728-0BC6-4A0D-AE12-337FE5DE380FQ30244309-422A6A7B-3945-462B-9043-26B5FBCDC114Q30245322-00528A9F-E434-438B-B51F-05E75FAF7D25Q30251616-BFC1A324-FD9F-41F7-ADB6-CF0BC14F316CQ30397342-B1B9B514-42A0-4E94-9404-0907C7F93994Q31060798-BA31211D-5147-4A94-AED2-76471FEF706BQ33381069-C263158E-BE53-497B-90B3-4AF029FDEA4CQ33406200-9615D67F-135B-4B13-AD2F-09A253091AB0Q33412110-BD5A484F-1A82-4D95-9E08-957C996C5F57Q33575500-03E0B850-97FC-4CCF-A574-7FD16995D80EQ34068668-0EAE6760-9E67-4598-A6A7-CF290BCF06A5Q35177338-55B8C4D3-1910-44A1-9F8C-5A63DD45A0FAQ35589474-C27B5190-4D6F-4622-B406-736D3C7E28CAQ37288126-A90DD0FB-D364-4692-8A9B-9A36E5347B6EQ37549738-1B6610FC-6795-42BD-B273-E630C24E4DD5Q37564012-3A0ADF40-35F6-48FD-B07A-482A89524C9DQ37771975-737A8CBA-33AD-4A6F-9974-25EFC7377EF9Q37877259-9E2B553C-529A-4CB1-8A16-8C30B397450EQ37979841-659B169D-4B27-4BCE-ADEC-3C1D660706F0Q38021422-A4D031C7-30A6-4447-9B18-191385511881Q38023828-36740B24-579B-43DE-9526-9431B9D07CECQ38111423-35410516-66B2-4FC4-981A-B5CF23EBAA3BQ38167805-2F41045B-BA1B-4793-A05F-1C758FDB03A6Q38180715-592B1D85-9B71-4C38-891C-A6C50F33AE78Q38207074-739C870B-87A3-45EE-9349-E8E4561F3CEBQ38306637-E630014E-B70D-464B-A90E-9C9BE2EE58A6Q38406282-E62AA8DF-0F62-419C-8992-098C8A6971F1Q38569717-4D047423-B22C-4A28-BA83-3D084AFB08FDQ38573627-1F20433D-1783-44D1-80B7-984697A61C45Q38614953-F6F0CEBA-1CAC-477E-85EC-76B8672C5FBFQ38626282-9B2397F5-DDD7-4C9F-8E88-1E6A0A8B1053Q38680451-039B390E-4A16-4376-85AC-54D5ED20F37EQ38706233-25DA2961-FCE6-471C-B3E6-C13C02AB76F2Q38713832-6A069618-0FF4-4349-8F36-F534C7A0C1B2Q38767112-0F2F0DA6-4AF1-4A8F-B959-F121003FAA65Q38781592-B29EB374-0336-4065-AB0C-8FE4D7011E10Q38856255-A828322F-55DF-4EE8-9A58-0ED945ACBF0CQ38949580-A6D2E786-4477-4775-A7BA-7EE4CC937C15Q38951070-E2A1D355-B8ED-4A1F-8A7F-F6CCB86E0568
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Hassan Abolhassani
@ast
Hassan Abolhassani
@en
Hassan Abolhassani
@es
Hassan Abolhassani
@nl
Hassan Abolhassani
@sl
type
label
Hassan Abolhassani
@ast
Hassan Abolhassani
@en
Hassan Abolhassani
@es
Hassan Abolhassani
@nl
Hassan Abolhassani
@sl
prefLabel
Hassan Abolhassani
@ast
Hassan Abolhassani
@en
Hassan Abolhassani
@es
Hassan Abolhassani
@nl
Hassan Abolhassani
@sl
P214
P106
P214
P31
P496
0000-0002-4838-0407
P7859
viaf-305752703